February 12, 2016

Bay Area TBA

The California Technology Assessment Forum (CTAF), a core program of the Institute for Clinical and Economic Review (ICER), will hold a public meeting in February 2016 to discuss the comparative effectiveness and value of a drug for patients with diabetes (type 1 and type 2) and another drug for patients with severe eosinophilic asthma.

Learn more
Subscribe to Meetings